RecruitingNCT06533410

Using the Chinese Indigenization FS Scale in the Diagnosis of Fibromyalgia： Specificity and Sensitivity in Clinical Practice

Sponsor

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Enrollment

59 participants

Start Date

May 21, 2024

Study Type

OBSERVATIONAL

Conditions

Fibromyalgia

Summary

This study aimed to evaluate the specificity and sensitivity of the diagnostic criteria for fibromyalgia after conducting local validation in China.

Eligibility

Min Age: 18 Years

Inclusion Criteria1

At least 18 years of age; Patients with chronic widespread pain; Able to complete the questionnaire.

Exclusion Criteria1

Terminal patients with severe psychiatric diseases, tumors, systemic lupus erythematosus, systemic sclerosis, or other serious diseases.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTThe FM Diagnosis and Assessment Scale will be filled out, and there will be no other interventions beyond that

The FM Diagnosis and Assessment Scale will be filled out, and there will be no other interventions beyond that

Locations(1)

Guang'anmen Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06533410

Related Trials

Pain Processing in Inflammatory and Non-Inflammatory Chronic Pain Syndromes

NCT052770251 location

Mindfulness-based Rehabilitation in a University Museum Setting to Reduce Pain and Improve Quality of Life in Women With Fibromyalgia: a Randomized Controlled Trial

NCT070483662 locations